299 related articles for article (PubMed ID: 25298424)
1. The role of proteases in excitation-contraction coupling failure in muscular dystrophy.
Mázala DA; Grange RW; Chin ER
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C33-40. PubMed ID: 25298424
[TBL] [Abstract][Full Text] [Related]
2. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
3. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.
Mázala DA; Pratt SJP; Chen D; Molkentin JD; Lovering RM; Chin ER
Am J Physiol Cell Physiol; 2015 May; 308(9):C699-709. PubMed ID: 25652448
[TBL] [Abstract][Full Text] [Related]
4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
5. Excitation-contraction coupling alterations in mdx and utrophin/dystrophin double knockout mice: a comparative study.
Capote J; DiFranco M; Vergara JL
Am J Physiol Cell Physiol; 2010 May; 298(5):C1077-86. PubMed ID: 20130206
[TBL] [Abstract][Full Text] [Related]
6. Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice.
Schertzer JD; van der Poel C; Shavlakadze T; Grounds MD; Lynch GS
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C161-8. PubMed ID: 17989207
[TBL] [Abstract][Full Text] [Related]
7. TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.
Call JA; Ervasti JM; Lowe DA
J Appl Physiol (1985); 2011 Jul; 111(1):200-5. PubMed ID: 21565990
[TBL] [Abstract][Full Text] [Related]
8. In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin-lacking mdx mice.
Gailly P; De Backer F; Van Schoor M; Gillis JM
J Physiol; 2007 Aug; 582(Pt 3):1261-75. PubMed ID: 17510188
[TBL] [Abstract][Full Text] [Related]
9. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
11. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
15. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
[TBL] [Abstract][Full Text] [Related]
16. Rapid restitution of contractile dysfunction by synthetic copolymers in dystrophin-deficient single live skeletal muscle fibers.
Hahn D; Quick JD; Thompson BR; Crabtree A; Hackel BJ; Bates FS; Metzger JM
Skelet Muscle; 2023 May; 13(1):9. PubMed ID: 37208786
[TBL] [Abstract][Full Text] [Related]
17. Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle.
Roy P; Rau F; Ochala J; Messéant J; Fraysse B; Lainé J; Agbulut O; Butler-Browne G; Furling D; Ferry A
Skelet Muscle; 2016; 6():23. PubMed ID: 27441081
[TBL] [Abstract][Full Text] [Related]
18. Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy.
Janssen PM; Murray JD; Schill KE; Rastogi N; Schultz EJ; Tran T; Raman SV; Rafael-Fortney JA
PLoS One; 2014; 9(2):e88360. PubMed ID: 24551095
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.
Kumar A; Bhatnagar S; Kumar A
Am J Pathol; 2010 Jul; 177(1):248-60. PubMed ID: 20472898
[TBL] [Abstract][Full Text] [Related]
20. Social stress is lethal in the mdx model of Duchenne muscular dystrophy.
Razzoli M; Lindsay A; Law ML; Chamberlain CM; Southern WM; Berg M; Osborn J; Engeland WC; Metzger JM; Ervasti JM; Bartolomucci A
EBioMedicine; 2020 May; 55():102700. PubMed ID: 32192914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]